NCT05986916Active, not recruiting
Accurate Point of Care Liver Disease Diagnostics
Source: ClinicalTrials.gov · Last updated 23 Oct 2025
Brief summary (registry, in English)
This research study is being conducted to find out more about techniques to non-invasively evaluate liver disease. The investigators are testing a new technology to evaluate the liver (LiverScope®), and they will compare it to other methods to evaluate the liver, including advanced conventional liver MR and liver FibroScan® ultrasound exams. MR exams and FibroScan® ultrasound exams are common exams used to monitor NAFLD. Conventional MR scanners use magnetic fields and radio waves to make pictures of the liver. LiverScope® is a small, portable MR-based device that uses similar, but simplified technology, and can be used on top of an exam table in an outpatient setting. LiverScope® currently is not approved for clinical use. In this study the investigators will learn how LiverScope® measurements of the liver compare to MR. Study participants will be asked to complete a one-time visit which includes: * LiverScope exam * MR exam * FibroScan exam (optional) * Blood draw * Completion of study questionnaires
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 50 (estimated)
- First submitted
- 1 Aug 2023
- Start date
- 3 Aug 2023
- Primary completion date
- 30 Nov 2025
- Lead sponsor
- University of California, San Diego
- Diseases
- Fatty liver disease (MASLD/MASH)
- NCT number
- NCT05986916
What you commit to
- Study type: Observational
- Planned participants: 50
- From 3 Aug 2023 to the primary completion date, 30 Nov 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Known chronic liver disease other than NAFLD
Other
- VA patient only; not a UCSD patient
- UCSD or Livivos study personnel
- MR contraindication(s)
- Potential participant states that she knows that she is pregnant, thinks she may be pregnant or states she is trying to become pregnant\*
Who the study is looking for
- Age:18 years or older
- Known or clinically suspected NAFLD
- Weight less than 350 lbs (safety limit of MR scanner table)
- Able to lie on LiverScope® diagnostic table for about 15 min
- Able to hold breath repeatedly for about 20 s during MR and LiverScope® exams
- Willing and able to undergo all study procedures
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of California San Diego Coordinator of this site? Confirm its status | La Jolla | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.